**Chapter 5**

*Oncogenes and Carcinogenesis*

significance? International Journal of Colorectal Disease. 2009;**24**:613-622. DOI: 10.1007/s00384-009-0647-9

[100] Dasgupta S, Lonard DM, O'Malley BW. Nuclear receptor coactivators: Master regulators of human health and disease. Annual Review of Medicine. 2014;**65**:279-292. DOI: 10.1146/ annurev-med-051812-145316

Rasmussen BB, Bendahl P-O, Fernö M, Rydén L, et al. Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: The Danish cohort of BIG 1-98. Breast Cancer Research and Treatment. 2017;**166**:481-490. DOI:

[102] Alkner S, Bendahl P-O, Ehinger A, Lövgren K, Rydén L, Fernö M. Prior adjuvant tamoxifen treatment in breast cancer is linked to increased AIB1 and HER2 expression in metachronous contralateral breast cancer. PLoS One. 2016;**11**:e0150977. DOI: 10.1371/journal.

[103] Wang Y, Lonard DM, Yu Y, Chow D-C, Palzkill TG, Wang J, et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Research. 2014;**74**:1506-1517. DOI: 10.1158/0008-

[104] Song X, Chen J, Zhao M, Zhang C, Yu Y, Lonard DM, et al. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proceedings of the National Academy of Sciences of the United States of America. 2016;**113**:4970-4975. DOI: 10.1073/

[105] Wang L, Yu Y, Chow D-C, Yan F, Hsu C-C, Stossi F, et al. Characterization of a steroid receptor coactivator small molecule stimulator that overstimulates cancer cells and leads to cell stress and death. Cancer Cell. 2015;**28**:240-252. DOI: 10.1016/j.ccell.2015.07.005

[101] Alkner S, Jensen M-B,

10.1007/s10549-017-4416-0

pone.0150977

5472.CAN-13-2939

pnas.1604274113

[94] Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, et al. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling. Oncogene. 2014;**34**:3935-

3945. DOI: 10.1038/onc.2014.324

[95] Guo S, Xu J, Xue R, Liu Y, Yu H. Overexpression of AIB1 correlates inversely with E-cadherin expression in pancreatic adenocarcinoma and may promote lymph node metastasis. International Journal of Clinical Oncology. 2014;**19**:319-324. DOI: 10.1007/s10147-013-0549-2

[96] Liu M-Y, Guo H-P, Hong C-Q , Peng H-W, Yang X-H, Zhang

s12094-013-1029-x

2005;**11**:865s-870s

Institute. 2004;**96**:926-935

H. Up-regulation of nuclear receptor coactivator amplified in breast

cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis. Clinical & Translational Oncology. 2013;**15**:947-952. DOI: 10.1007/

[97] Osborne CK, Shou J, Massarweh S, Schiff R. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clinical Cancer Research.

[98] Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, et al. Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. Journal of the National Cancer

[99] Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature. 2008;**456**:663-666. DOI: 10.1038/

**70**

nature07483
